{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:10:57Z","timestamp":1793459457676,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003382","name":"AMED-CREST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research on Development of New Drugs program of the Japan Agency for Medical Research and Development"},{"name":"AMED-SATREPS"},{"name":"AMED-Practical Research Project for Allergic Diseases and Immunology"},{"name":"MEXT KAKENHI","award":["25870715"],"award-info":[{"award-number":["25870715"]}]},{"name":"the Japan Health Foundation; and the Mochida Memorial Foundation for Medical and Pharmaceutical Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.molimm.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T02:18:49Z","timestamp":1509502729000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Nanogel-based nasal vaccines for infectious and lifestyle-related diseases"],"prefix":"10.1016","volume":"98","author":[{"given":"Tatsuhiko","family":"Azegami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2017.10.022_bib0005","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1021\/ma00064a011","article-title":"Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles","volume":"26","author":"Akiyoshi","year":"1993","journal-title":"Macromolecules"},{"key":"10.1016\/j.molimm.2017.10.022_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/bc9801272","article-title":"Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: thermal stabilization with refolding of carbonic anhydrase B","volume":"10","author":"Akiyoshi","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.molimm.2017.10.022_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0897190012442351","article-title":"Bioterrorism: toxins as weapons","volume":"25","author":"Anderson","year":"2012","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.molimm.2017.10.022_bib0020","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/bc700422s","article-title":"Self-assembled cationic nanogels for intracellular protein delivery","volume":"19","author":"Ayame","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.molimm.2017.10.022_bib0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/hr.2011.212","article-title":"Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy","volume":"35","author":"Azegami","year":"2012","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.molimm.2017.10.022_bib0030","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/mi.2016.137","article-title":"Nanogel-based nasal ghrelin vaccine prevents obesity","volume":"10","author":"Azegami","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0035","article-title":"Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents","author":"Azegami","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.molimm.2017.10.022_bib0040","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2003.09.032","article-title":"Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine","volume":"22","author":"Bellanti","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2017.10.022_bib0050","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type a binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2017.10.022_bib0055","series-title":"Bioterrorism Overview","author":"CDC","year":"2007"},{"key":"10.1016\/j.molimm.2017.10.022_bib0060","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1016\/j.vaccine.2011.08.121","article-title":"Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0065","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1016\/j.vaccine.2013.05.020","article-title":"Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice","volume":"31","author":"Camacho","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/02652048.2015.1073393","article-title":"Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies","volume":"32","author":"Cevher","year":"2015","journal-title":"J. Microencapsulation"},{"key":"10.1016\/j.molimm.2017.10.022_bib0075","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0264-410X(02)00545-5","article-title":"Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine","volume":"14","author":"Coulter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0080","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/iai.58.10.3293-3299.1990","article-title":"Pneumococcal surface protein a (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae","volume":"58","author":"Crain","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2017.10.022_bib0085","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/S0264-410X(02)00191-3","article-title":"Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses","volume":"20","author":"Debin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.08.032","article-title":"Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants","volume":"475","author":"Dehghan","year":"2014","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrd3739","article-title":"Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons","volume":"11","author":"Dietrich","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molimm.2017.10.022_bib0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biomaterials.2015.01.056","article-title":"Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection","volume":"50","author":"Dimier-Poisson","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.molimm.2017.10.022_bib0105","first-page":"97","article-title":"Chitosan-based intranasal vaccine against Escherichia coli O157:H7","volume":"20","author":"Doavi","year":"2016","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.molimm.2017.10.022_bib0110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(97)00249-1","article-title":"Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0115","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/mi.2015.5","article-title":"Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques","volume":"8","author":"Fukuyama","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573406412666160720093138","article-title":"The role of size in development of mucosal liposome-lipopeptide vaccine candidates against group a streptococcus","volume":"13","author":"Ghaffar","year":"2016","journal-title":"Med. Chem."},{"key":"10.1016\/j.molimm.2017.10.022_bib0125","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1016\/j.vaccine.2011.09.033","article-title":"Development and characterization of chitosan coated poly-(varepsilon-caprolactone) nanoparticulate system for effective immunization against influenza","volume":"29","author":"Gupta","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2016.03.013","article-title":"Immune response elicitedby an intranasally delivered HBsAg low-dose adsorbed to poly-epsilon-caprolactone based nanoparticles","volume":"504","author":"Jesus","year":"2016","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1349-7006.2007.00705.x","article-title":"Humoral immune responses in patients vaccinated with 1\u2013146 HER2 protein complexed with cholesteryl pullulan nanogel","volume":"99","author":"Kageyama","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.molimm.2017.10.022_bib0140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1479-5876-11-246","article-title":"Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients","volume":"11","author":"Kageyama","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2017.10.022_bib0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.rvsc.2013.06.023","article-title":"Immunogenetic responses in calves to intranasal delivery of bovine respiratory syncytial virus (BRSV) epitopes encapsulated in poly (DL-lactide-co-glycolide) microparticles","volume":"95","author":"Kavanagh","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.molimm.2017.10.022_bib0150","series-title":"Fundamental Immunology","first-page":"983","article-title":"The mucosal immune system","author":"Kiyono","year":"2008"},{"key":"10.1016\/j.molimm.2017.10.022_bib0155","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.00240-13","article-title":"Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae","volume":"81","author":"Kong","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2017.10.022_bib0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000222674","article-title":"Local nasal immunotherapy: efficacy of Dermatophagoides farinae-chitosan vaccine in murine asthma","volume":"150","author":"Liu","year":"2009","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0165","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/jmv.24253","article-title":"Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration","volume":"87","author":"Liu","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12917-015-0481-y","volume":"11","author":"Mansoor","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.molimm.2017.10.022_bib0175","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijpharm.2016.09.057","article-title":"Lipid core peptide\/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against group A streptococcus","volume":"513","author":"Marasini","year":"2016","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0180","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/infdis\/jit636","article-title":"Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus","volume":"209","author":"Misstear","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2017.10.022_bib0185","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2017.10.022_bib0190","doi-asserted-by":"crossref","first-page":"471468","DOI":"10.1155\/2015\/471468","article-title":"Cholesteryl pullulan encapsulated TNF-alpha nanoparticles are an effective mucosal vaccine adjuvant against influenza virus","volume":"2015","author":"Nagatomo","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.molimm.2017.10.022_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00100-3","article-title":"Screening of cationic compounds as an absorption enhancer for nasal drug delivery","volume":"185","author":"Natsume","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molimm.2017.10.022_bib0200","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/S0264-410X(02)00261-X","article-title":"Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice","volume":"20","author":"Ninomiya","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0205","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1021\/ja953843c","article-title":"Macromolecular complex between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides","volume":"118","author":"Nishikawa","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molimm.2017.10.022_bib0210","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.molimm.2017.10.022_bib0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12916-016-0735-y","article-title":"Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.molimm.2017.10.022_bib0220","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.2147\/IJN.S72318","article-title":"Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles","volume":"9","author":"Pan","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.molimm.2017.10.022_bib0225","first-page":"E1256","article-title":"Therapeutic vaccine against DPP4 improves glucose metabolism in mice","volume":"111","author":"Pang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molimm.2017.10.022_bib0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10717544.2014.908427","article-title":"Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response","volume":"23","author":"Pawar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.molimm.2017.10.022_bib0235","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejpb.2013.06.017","article-title":"Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity","volume":"85","author":"Pawar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.molimm.2017.10.022_bib0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrendo.2015.6","article-title":"Novel RAAS agonists and antagonists: clinical applications and controversies","volume":"11","author":"Romero","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0245","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1016\/j.vaccine.2012.06.035","article-title":"Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: impact of formulation on physicochemical and immunological characteristics","volume":"30","author":"Tafaghodi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.10.022_bib0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/mi.2010.50","article-title":"Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic","volume":"4","author":"Tai","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0255","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","article-title":"Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study","volume":"371","author":"Tissot","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2017.10.022_bib0260","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tschop","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2017.10.022_bib0265","series-title":"Pneumococcaldisease","author":"WHO,","year":"2011"},{"key":"10.1016\/j.molimm.2017.10.022_bib0270","series-title":"Botulism Fact Sheet","author":"WHO","year":"2016"},{"key":"10.1016\/j.molimm.2017.10.022_bib0275","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.4049\/jimmunol.1001789","article-title":"In vivo molecular imaging analysis of a nasal vaccine that induces protective immunity against botulism in nonhuman primates","volume":"185","author":"Yuki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.10.022_bib0280","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2217\/nnm.14.190","article-title":"Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity","volume":"9","author":"Zaman","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.molimm.2017.10.022_bib0285","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1172\/JCI26002","article-title":"Mice lacking ghrelin receptors resist the development of diet-induced obesity","volume":"115","author":"Zigman","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2017.10.022_bib0290","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.1073\/pnas.0605376103","article-title":"Vaccination against weight gain","volume":"103","author":"Zorrilla","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017305515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017305515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:28:45Z","timestamp":1758979725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589017305515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":58,"alternative-id":["S0161589017305515"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.10.022","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanogel-based nasal vaccines for infectious and lifestyle-related diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}